These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18157011)

  • 21. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
    Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
    Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
    Winter H; Hu HM; McClain K; Urba WJ; Fox BA
    J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice.
    Brück J; Steitz J; Strand D; Tüting T
    J Gene Med; 2005 May; 7(5):613-20. PubMed ID: 15580620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer.
    Tian C; Bagley J; Kaye J; Iacomini J
    J Gene Med; 2003 May; 5(5):359-65. PubMed ID: 12731084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
    Errington F; Bateman A; Kottke T; Thompson J; Harrington K; Merrick A; Hatfield P; Selby P; Vile R; Melcher A
    Clin Cancer Res; 2006 Feb; 12(4):1333-41. PubMed ID: 16489091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
    Nishimura F; Dusak JE; Eguchi J; Zhu X; Gambotto A; Storkus WJ; Okada H
    Cancer Res; 2006 Apr; 66(8):4478-87. PubMed ID: 16618775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.
    Poehlein CH; Hu HM; Yamada J; Assmann I; Alvord WG; Urba WJ; Fox BA
    J Immunol; 2003 Feb; 170(4):2004-13. PubMed ID: 12574370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.
    Gassara A; Messai Y; Gaudin C; Abouzahr S; Jalil A; Diarra-Mehrpour M; Faure F; Richon C; Avril MF; Even J; Chouaib S
    Int J Oncol; 2006 Jul; 29(1):155-61. PubMed ID: 16773195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased tumor surveillance after adoptive T-cell therapy.
    Matter M; Pavelic V; Pinschewer DD; Mumprecht S; Eschli B; Giroglou T; von Laer D; Ochsenbein AF
    Cancer Res; 2007 Aug; 67(15):7467-76. PubMed ID: 17671217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
    Ishida A; Tanaka H; Hiura T; Miura S; Watanabe S; Matsuyama K; Kuriyama H; Tanaka J; Kagamu H; Gejyo F; Yoshizawa H
    Scand J Immunol; 2007 Nov; 66(5):546-54. PubMed ID: 17953530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.
    Górka M; Lamparska-Przybysz M; Motyl T
    Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL915-22. PubMed ID: 17666167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay.
    Ewen CL; Rong J; Kokaji AI; Bleackley RC; Kane KP
    J Immunol Methods; 2006 Jan; 308(1-2):156-66. PubMed ID: 16375915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.
    Thanarajasingam U; Sanz L; Diaz R; Qiao J; Sanchez-Perez L; Kottke T; Thompson J; Chester J; Vile RG
    Cancer Res; 2007 Jan; 67(1):300-8. PubMed ID: 17210711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-specific T cells combine proliferation and antitumor activity.
    Kershaw MH; Westwood JA; Hwu P
    Nat Biotechnol; 2002 Dec; 20(12):1221-7. PubMed ID: 12415288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer.
    Sekimura A; Konishi A; Mizuno K; Kobayashi Y; Sasaki H; Yano M; Fukai I; Fujii Y
    Oncol Rep; 2004 Apr; 11(4):797-802. PubMed ID: 15010875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Smac gene over-expression on the radiotherapeutic sensitivities of cervical cancer cell line HeLa.
    Zheng LD; Xiong ZF; Zhu JW; Wang ZH
    Chin Med J (Engl); 2005 Feb; 118(3):226-30. PubMed ID: 15740652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.
    Pardo J; Bosque A; Brehm R; Wallich R; Naval J; Müllbacher A; Anel A; Simon MM
    J Cell Biol; 2004 Nov; 167(3):457-68. PubMed ID: 15534000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Overexpression of Smac gene enhanced chemotherapeutic sensitivity of esophageal cancer cell line Eca109 to cisplatin].
    Du N; Yang B; Hu LJ; Zhao Y; Sun X; Guo ZW; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):344-6. PubMed ID: 22482401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood donor derived dendritic cells and cytotoxic T cells for specific fusion-gene adoptive immunotherapy.
    Gallagher RC; Waterfall M; Samuel K; Turner ML
    Vox Sang; 2007 May; 92(4):351-60. PubMed ID: 17456159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.